|
EP3725765A1
|
|
A process for the preparation of enantiomerically pure norepinephrine
|
|
US2014243529A1
|
|
Process for the preparation of lurasidone hydrochloride
|
|
BR102013004752A2
|
|
process for the resolution of medetomidine enantiomers
|
|
EP2284161A1
|
|
Process for the preparation of riluzole
|
|
EP2060568A1
|
|
Polymorphs of enantiopure erdosteine
|
|
EP1964838A1
|
|
Process for the resolution of homocysteine-thiolactone
|
|
EP1857106A1
|
|
Combinations of erdosteine and beta-2 agonists for treating COPD
|
|
EP0974353A2
|
|
The use of homocysteine derivatives for the treatment of bacterial infections
|
|
EP0610481A1
|
|
Extraction of collagen
|
|
ITMI931371D0
|
|
Process for the preparation of erdosteine
|
|
ITMI931254D0
|
|
Extn. of a new form of collagen - by treating collagenous tissue with an alkaline hydroxide soln., neutralising and extn. with acid soln.
|
|
WO9325573A1
|
|
Salts of a glutathione alkylester and anaminoacids
|
|
EP0593697A1
|
|
Mercapto-acetamide derivatives
|
|
EP0295476A2
|
|
Inclusion complexes of dipyridamole with cyclodextrins
|
|
BE904614A
|
|
Process for the preparation of diosmine.
|
|
IT8619931D0
|
|
Methyl-amidino-di:methyl-phenylurea (salts)
|
|
FR2595355A1
|
|
New silver salt derived from quinolone, useful in particular as antibacterial, and its manufacture
|
|
PT80095A
|
|
Erythromycin salts with derivatives of acetic acid procedure for their preparation and pharmaceutical compositions that contain them
|
|
BE901511A
|
|
Nicotinoyl ester(s) of pantethine - for treatment of atherosclerosis and other cholesterol and lipid disorders
|
|
CH661435A5
|
|
Pantetina derivatives, their salts, procedure for their preparation and pharmaceutical compositions containing them.
|
